Tailored eradication strategy <i>vs</i> concomitant therapy for <i>Helicobacter pylori</i> eradication treatment in Korean patients

Abstract

The DPO-based TT regimen shows promising results in efficacy and safety profiles as a first-line <i>Helicobacter</i> eradication regimen in Korea, especially when physicians are confronted with increased antibiotic resistance rates.